Physician

Charles C Sung, MD

According to 2025 Medicare claims, Charles Sung, MD (NPI: 1275532996) practices ophthalmology in the Kennewick-Richland, WA market, with the plurality of this provider's patient population coming from Benton, WA. This provider's primary affiliated billing organization is CHARLES SUNG MD PC (NPI: 1245358050; TIN: 911920503) and primary practice location at 99336-7750.

Sung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 121 traditional Medicare patients, billed 26,578 HCPCS/CPT codes, and received $1,077,361 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 181 prescription claims across 62 beneficiaries totaling $17,275 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 4 records totaling $94. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$5.1M2015 Medicare payment: $3,227,739 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,006,772 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,034,228 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,747,143 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,060,435 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,026,701 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,833,152 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,252,183 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,228,231 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,077,361 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,33736,535$3,227,739
20161,53731,668$3,006,772
20171,59636,713$3,034,228
20181,44230,710$3,747,143
20191,44331,751$5,060,435
20201,22628,069$5,026,701
20211,01225,389$4,833,152
202290521,358$4,252,183
202364142,032$3,228,231
202412126,578$1,077,361

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$49K$98K2015 Drug cost: $45,933 (USD; Tot_Drug_Cst)2016 Drug cost: $65,982 (USD; Tot_Drug_Cst)2017 Drug cost: $97,776 (USD; Tot_Drug_Cst)2018 Drug cost: $88,389 (USD; Tot_Drug_Cst)2019 Drug cost: $83,089 (USD; Tot_Drug_Cst)2020 Drug cost: $93,231 (USD; Tot_Drug_Cst)2021 Drug cost: $91,466 (USD; Tot_Drug_Cst)2022 Drug cost: $75,087 (USD; Tot_Drug_Cst)2023 Drug cost: $55,347 (USD; Tot_Drug_Cst)2024 Drug cost: $17,275 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015279955$45,933
20163301,227$65,982
20173751,555$97,776
20183561,385$88,389
20192631,123$83,089
20202931,381$93,231
20212971,248$91,466
20222571,043$75,087
2023180631$55,347
202462181$17,275

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye99584$94
92014Established patient complete exam of visual system98209$89
92012Established patient problem focused exam of visual system97396$68
92134Imaging of retina121622$30
92250Photography of the retina103191$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost11455$4,258
LatanoprostLatanoprost513,924$814
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat302,128$578
Dorzolamide HclDorzolamide Hcl13749$385
Brimonidine TartrateBrimonidine Tartrate352,860$361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$94Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles C. Sung, MD?

Tedicare shows public-source Medicare data for Charles C. Sung, MD (NPI 1275532996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles C. Sung, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles C. Sung, MD?

Charles C. Sung, MD is linked to CHARLES SUNG MD PC (billing NPI 1245358050) in the available physician profile data.

Does Charles C. Sung, MD have Open Payments data?

Charles C. Sung, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.